Ben Derman

No followers

community-curated profile

Asst Professor at University of Chicago, specializing in (vanquishing) plasma cell disorders. I tweet about: Myeloma & MRD. https://linktr.ee/bderman

Overview Content

Tweet Jan 24, 2023

Results of ALLO-715, an allogeneic BCMA-targeting CAR T cell therapy are published. Novel features to this product: ‼️ Has rituximab kill switch ‼️ Knockout of the T cell receptor alpha constant (TRAC) to reduce GVHD risk ‼️ Knockout CD52 /1 #mmsm w

by Ben Derman

Recommended by 1 person

1 mention